Company Filing History:
Years Active: 2017
Title: Toshiaki Nakano: Innovator in Immunosuppressive Antibodies
Introduction
Toshiaki Nakano is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of immunology through his innovative research and development of monoclonal antibodies.
Latest Patents
Toshiaki Nakano holds a patent for a monoclonal antibody having immunosuppressive activity or an antigen binding fragment thereof. This invention relates to a monoclonal antibody that exhibits excellent immunosuppressive activity. More specifically, it binds to a peptide consisting of an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1) or a conjugate of the peptide and a pharmaceutically acceptable carrier. The monoclonal antibody or its antigen binding fragment demonstrates a higher binding affinity for core histone than for histone H1. He has 1 patent to his name.
Career Highlights
Toshiaki Nakano is affiliated with Josai University Corporation, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Toshiaki Nakano has collaborated with notable colleagues, including Shuji Sato and Takeshi Goto, to further enhance the impact of his research.
Conclusion
Toshiaki Nakano's innovative work in the development of immunosuppressive antibodies marks a significant advancement in the field of immunology. His contributions continue to influence research and potential therapeutic applications.